Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston 02115, USA.
Int J Gynaecol Obstet. 2011 Oct;115(1):11-5. doi: 10.1016/j.ijgo.2011.05.011. Epub 2011 Jul 20.
The past 2 decades have seen a significant rise in cancer survival rates, and an increasing proportion of survivors at reproductive age are interested in childbearing. Although assisted reproduction provides physicians with an array of potential possibilities to help patients whose fertility is compromised by cancer treatment, there is still a dearth of regulation regarding the application of this technology. The present paper reviews the current options for fertility preservation, with a particular focus on the legal and ethical challenges that confront providers of this type of care.
在过去的 20 年中,癌症患者的生存率显著提高,越来越多处于生育年龄的幸存者对生育感兴趣。虽然辅助生殖为因癌症治疗而生育能力受损的患者提供了一系列潜在的可能性,但关于该技术的应用仍缺乏监管。本文回顾了目前的生育力保存选择,特别关注为这类治疗提供服务的提供者所面临的法律和伦理挑战。